Literature DB >> 22036586

A unified model of mammalian BCL-2 protein family interactions at the mitochondria.

Fabien Llambi1, Tudor Moldoveanu, Stephen W G Tait, Lisa Bouchier-Hayes, Jamshid Temirov, Laura L McCormick, Christopher P Dillon, Douglas R Green.   

Abstract

During apoptosis, the BCL-2 protein family controls mitochondrial outer membrane permeabilization (MOMP), but the dynamics of this regulation remain controversial. We employed chimeric proteins composed of exogenous BH3 domains inserted into a tBID backbone that can activate the proapoptotic effectors BAX and BAK to permeabilize membranes without being universally sequestered by all antiapoptotic BCL-2 proteins. We thus identified two "modes" whereby prosurvival BCL-2 proteins can block MOMP, by sequestering direct-activator BH3-only proteins ("MODE 1") or by binding active BAX and BAK ("MODE 2"). Notably, we found that MODE 1 sequestration is less efficient and more easily derepressed to promote MOMP than MODE 2. Further, MODE 2 sequestration prevents mitochondrial fusion. We provide a unified model of BCL-2 family function that helps to explain otherwise paradoxical observations relating to MOMP, apoptosis, and mitochondrial dynamics.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036586      PMCID: PMC3221787          DOI: 10.1016/j.molcel.2011.10.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  40 in total

1.  Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane.

Authors:  R Eskes; S Desagher; B Antonsson; J C Martinou
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX.

Authors:  Bonsu Ku; Chengyu Liang; Jae U Jung; Byung-Ha Oh
Journal:  Cell Res       Date:  2010-11-09       Impact factor: 25.617

3.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

Authors:  Anthony Letai; Michael C Bassik; Loren D Walensky; Mia D Sorcinelli; Solly Weiler; Stanley J Korsmeyer
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

4.  Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane.

Authors:  Tomomi Kuwana; Mason R Mackey; Guy Perkins; Mark H Ellisman; Martin Latterich; Roger Schneiter; Douglas R Green; Donald D Newmeyer
Journal:  Cell       Date:  2002-11-01       Impact factor: 41.582

Review 5.  Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics.

Authors:  Jean-Claude Martinou; Richard J Youle
Journal:  Dev Cell       Date:  2011-07-19       Impact factor: 12.270

6.  tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c.

Authors:  M C Wei; T Lindsten; V K Mootha; S Weiler; A Gross; M Ashiya; C B Thompson; S J Korsmeyer
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

7.  Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol.

Authors:  Frank Edlich; Soojay Banerjee; Motoshi Suzuki; Megan M Cleland; Damien Arnoult; Chunxin Wang; Albert Neutzner; Nico Tjandra; Richard J Youle
Journal:  Cell       Date:  2011-04-01       Impact factor: 41.582

8.  The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis.

Authors:  S Frank; B Gaume; E S Bergmann-Leitner; W W Leitner; E G Robert; F Catez; C L Smith; R J Youle
Journal:  Dev Cell       Date:  2001-10       Impact factor: 12.270

Review 9.  Still embedded together binding to membranes regulates Bcl-2 protein interactions.

Authors:  B Leber; J Lin; D W Andrews
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

10.  Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis.

Authors:  Mariusz Karbowski; Yang-Ja Lee; Brigitte Gaume; Seon-Yong Jeong; Stephan Frank; Amotz Nechushtan; Ansgar Santel; Margaret Fuller; Carolyn L Smith; Richard J Youle
Journal:  J Cell Biol       Date:  2002-12-23       Impact factor: 10.539

View more
  255 in total

1.  Selectively targeting Mcl-1 for the treatment of acute myelogenous leukemia and solid tumors.

Authors:  Gregory J Gores; Scott H Kaufmann
Journal:  Genes Dev       Date:  2012-02-15       Impact factor: 11.361

2.  Mitochondrial pathway of apoptosis is ancestral in metazoans.

Authors:  Cheryl E Bender; Patrick Fitzgerald; Stephen W G Tait; Fabien Llambi; Gavin P McStay; Douglas O Tupper; Jason Pellettieri; Alejandro Sánchez Alvarado; Guy S Salvesen; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-13       Impact factor: 11.205

Review 3.  Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.

Authors:  Joseph T Opferman
Journal:  FEBS J       Date:  2015-09-15       Impact factor: 5.542

Review 4.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

5.  Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.

Authors:  S Colak; C D Zimberlin; E Fessler; L Hogdal; P R Prasetyanti; C M Grandela; A Letai; J P Medema
Journal:  Cell Death Differ       Date:  2014-03-28       Impact factor: 15.828

6.  The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Authors:  Ariele Viacava Follis; Fabien Llambi; Li Ou; Katherine Baran; Douglas R Green; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

7.  Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL.

Authors:  Dominic P Del Re; Takahisa Matsuda; Peiyong Zhai; Yasuhiro Maejima; Mohit Raja Jain; Tong Liu; Hong Li; Chiao-Po Hsu; Junichi Sadoshima
Journal:  Mol Cell       Date:  2014-05-08       Impact factor: 17.970

Review 8.  Mitochondrial mechanisms of neuronal rescue by F-68, a hydrophilic Pluronic block co-polymer, following acute substrate deprivation.

Authors:  Janice C Wang; Vytautas P Bindokas; Matthew Skinner; Todd Emrick; Jeremy D Marks
Journal:  Neurochem Int       Date:  2017-04-19       Impact factor: 3.921

9.  Contribution of Bcl-2 phosphorylation to Bak binding and drug resistance.

Authors:  Haiming Dai; Husheng Ding; X Wei Meng; Sun-Hee Lee; Paula A Schneider; Scott H Kaufmann
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

10.  Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma.

Authors:  Joachim C Mertens; Christian D Fingas; John D Christensen; Rory L Smoot; Steven F Bronk; Nathan W Werneburg; Michael P Gustafson; Allan B Dietz; Lewis R Roberts; Alphonse E Sirica; Gregory J Gores
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.